Talabostat (PT-100) T-cell independent anti-tumor activity cooperates with pemetrexed and erlotinib in A549 non-small cell lung cancer (NSCLC) xenograft model.

被引：0
|
作者：
Adams, S [1 ]
Surman, M [1 ]
Jones, B [1 ]
机构：
[1] Point Therapeut Inc, Boston, MA USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9157S / 9157S
页数：1
相关论文
共 50 条
  • [1] T-cell independent activity of talabostat (PT-100) against human tumor xenografts in mice
    Adams, S
    Miller, G
    Jones, B
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S54 - S54
  • [2] Determinants of erlotinib and pemetrexed synergism in non-small cell lung cancer (NSCLC) cell lines
    Giovannetti, E.
    Smid, K.
    Tekie, C.
    Mey, V.
    Nannizzi, S.
    Rodriguez, J. A.
    Danesi, R.
    Del Tacca, M.
    Giaccone, G.
    Peters, G. J.
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [3] Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model
    Suniket V. Fulzele
    Abhijit Chatterjee
    Madhu Sudhan Shaik
    Tanise Jackson
    Mandip Singh
    Pharmaceutical Research, 2006, 23 : 2094 - 2106
  • [4] Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model
    Fulzele, Suniket V.
    Chatterjee, Abhijit
    Sudhan Shaik, Madhu
    Jackson, Tanise
    Singh, Mandip
    PHARMACEUTICAL RESEARCH, 2006, 23 (09) : 2094 - 2106
  • [5] Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
    Zhang, Wei
    Peyton, Michael
    Xie, Yang
    Soh, Junichi
    Minna, John D.
    Gazdar, Adi F.
    Frenkel, Eugene P.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 161 - 166
  • [6] Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549
    Koparal, AT
    Zeytinoglu, M
    ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, 2003, : 207 - 211
  • [7] Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549
    Koparal, A. Tansu
    Zeytinoglu, Melih
    Cytotechnology, 1600, 1-3 (149-154):
  • [8] Effects of Carvacrol on a Human Non-Small Cell Lung Cancer (NSCLC) Cell Line, A549
    A. Tansu Koparal
    Melih Zeytinoglu
    Cytotechnology, 2003, 43 : 149 - 154
  • [9] Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549
    Koparal, AT
    Zeytinoglu, M
    CYTOTECHNOLOGY, 2003, 43 (1-3) : 149 - 154
  • [10] Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer
    Howe, Grant A.
    Xiao, Bin
    Zhao, Huijun
    Goss, Glenwood
    Addison, Christina L.
    CANCER RESEARCH, 2014, 74 (19)
12345